Advanced search
Publication Cover
Journal of Medical Economics Volume 20, 2017 - Issue 5
Submit an article Journal homepage
2,710
Views
41
CrossRef citations to date
0
Altmetric
Cardiovascular

Understanding the economic burden of heart failure in China: impact on disease management and resource utilization

Jun HuangThe First Affiliated Hospital of Nanjing Medical University, Nanjing, PR China;
,
Hongjun YinCentennial Scientific Co. Ltd., Warren, NJ, USA; Correspondence[email protected]
,
Milun ZhangNovartis Pharmaceuticals (China), Beijing, PR China;
,
Qian NiNovartis Pharmaceuticals (China), Beijing, PR China;
&
Jianwei XuanHealth Economics Research Institute, Sun Yat-sen University, Guagzhou, PR China
Pages 549-553 | Received 02 Dec 2016, Accepted 30 Jan 2017, Published online: 12 Mar 2017

Citations (41)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Maodong Ren, Dennis Xuan, Yongji Lu, YuYan Fu & Jianwei Xuan. (2020) Economic evaluation of olmesartan/amlodipine fixed-dose combination for hypertension treatment in China. Journal of Medical Economics 23:4, pages 394-400.
Read now
James DS Jackson, Sarah E Cotton, Sara Bruce Wirta, Catia C Proenca, Milun Zhang, Raquel Lahoz, Bogdan Balas & Frederico J Calado. (2018) Care pathways and treatment patterns for patients with heart failure in China: results from a cross-sectional survey. Drug Design, Development and Therapy 12, pages 2311-2321.
Read now

Articles from other publishers (39)

Mengyuan Fu, Can Li, Zinan Zhao, Kexin Ling, Zhiwen Gong, Huangqianyu Li, Ting Li, Jianchun Li, Weihang Cao, Xin Hu, Luwen Shi, Pengfei Jin & Xiaodong Guan. (2023) Potentially inappropriate medications among older patients with Parkinson’s disease: a cross-sectional analysis of a national health insurance database in China. BMC Geriatrics 23:1.
Crossref
Zahra Mahmoudi, Maryam Chenaghlou, Hossein Zare, Naser Safaei & Mahmood Yousefi. (2023) Heart failure: a prevalence-based and model-based cost analysis. Frontiers in Cardiovascular Medicine 10.
Crossref
Yanbo Zhu, Jianni Cong, Lin Lin, Jinhang Du, Liqun Long, Yuan He & Jiaju Ren. (2023) Minimum clinically important differences in the Minnesota Living with Heart Failure questionnaire: from a study of heart failure patients treated with integrated Chinese and Western medicine. Frontiers in Cardiovascular Medicine 10.
Crossref
Tao Shi, Yan Wang, Yunzhu Peng, Meifen Wang, Yanji Zhou, Wenyi Gu, Yanyan Li, Jie Zou, Na Zhu & Lixing Chen. (2023) Advanced lung cancer inflammation index combined with geriatric nutritional risk index predict all-cause mortality in heart failure patients. BMC Cardiovascular Disorders 23:1.
Crossref
Jingmin Zhou, Xuejuan Jin, Jun Zhou, Yamei Xu, Xiaotong Cui, Michael Fu, Kai Hu & Junbo Ge. (2023) Clinical outcomes by serum potassium levels for patients hospitalized for heart failure: Secondary analysis of data from the China National Heart Failure Registry. Clinical Cardiology 46:11, pages 1345-1352.
Crossref
Said Nabil. (2023) Comparison of International Guidelines for Managing Chronic Heart Failure with Reduced Ejection Fraction. Current Problems in Cardiology 48:10, pages 101867.
Crossref
Yi Tang & Haiqiang Sang. (2023) Cost‐utility analysis of add‐on dapagliflozin in heart failure with preserved or mildly reduced ejection fraction. ESC Heart Failure 10:4, pages 2524-2533.
Crossref
Siew Chin Ong & Joo Zheng Low. (2023) Financial burden of heart failure in Malaysia: A perspective from the public healthcare system. PLOS ONE 18:7, pages e0288035.
Crossref
Yilin Zhang, Danhua Hou, Xiaoyu Dong, Qiuge Zhao, Xiuting Zhang & Xiuzhen Fan. (2023) Determinants of depressive symptoms in patients with heart failure based on the hopelessness theory of depression. European Journal of Cardiovascular Nursing.
Crossref
Lei Zhou, Fei Peng, Juexing Li & Hui Gong. (2023) Exploring novel biomarkers in dilated cardiomyopathy‑induced heart failure by integrated analysis and in vitro experiments. Experimental and Therapeutic Medicine 26:1.
Crossref
Tianyang Hu, Yiting Liu & Yake Lou. (2023) Sacubitril–valsartan versus enalapril for the treatment of acute decompensated heart failure in Chinese settings: A cost-effectiveness analysis. Frontiers in Pharmacology 14.
Crossref
Yake Lou, Tianyang Hu & Jing Huang. (2022) Cost-Effectiveness of Adding Empagliflozin to Standard Treatment for Heart Failure with Preserved Ejection Fraction Patients in China. American Journal of Cardiovascular Drugs 23:1, pages 47-57.
Crossref
Haiqiang Sang, Yiming Wan, Zhenzhou Ma, Shengye Zhang & Qiuping Zhao. (2022) Cost-effectiveness of empagliflozin for the treatment of heart failure with reduced ejection fraction in China. Frontiers in Cardiovascular Medicine 9.
Crossref
SHENGCHANG DOU, SHILIANG SHAO, CHUNHE SONG, HAN SHI & HAI ZHAO. (2022) ELECTROCARDIOGRAM SIGNAL CLASSIFICATION ALGORITHM BASED ON THE CONTINUOUS WAVELET TRANSFORM AND GOOGLENET IN AN INTERNET OF THINGS CONTEXT. Journal of Mechanics in Medicine and Biology 22:09.
Crossref
Yi Tang & Haiqiang Sang. (2022) Cost-utility analysis of empagliflozin in heart failure patients with reduced and preserved ejection fraction in China. Frontiers in Pharmacology 13.
Crossref
Tiange Xu, Katya Loban, Xiaolin Wei & Wenhua Wang. (2022) Determinants of choice of usual source of care among older people with cardiovascular diseases in China: evidence from the Study on Global Ageing and Adult Health. BMC Public Health 22:1.
Crossref
Yaohui Jiang & Jun Xie. (2022) Cost-effectiveness of adding empagliflozin to the standard therapy for Heart Failure with Preserved Ejection Fraction from the perspective of healthcare systems in China. Frontiers in Cardiovascular Medicine 9.
Crossref
Junting Chi, Fei Chen, Jing Zhang, Xiaodan Niu, Hongxia Tao, Haihui Ruan, Lifen Jin & Yanhong Wang. (2022) Frailty is associated with 90-day unplanned readmissions and death in patients with heart failure: A longitudinal study in China. Heart & Lung 53, pages 25-31.
Crossref
Yaohui Jiang, Rujie Zheng & Haiqiang Sang. (2021) Cost-Effectiveness of Adding SGLT2 Inhibitors to Standard Treatment for Heart Failure With Reduced Ejection Fraction Patients in China. Frontiers in Pharmacology 12.
Crossref
Dunyi Liu, Ming Lu, Prakash Lakshmanan, Ziyi Hu & Xinping Chen. (2021) Increased Provision of Bioavailable Mg through Vegetables Could Significantly Reduce the Growing Health and Economic Burden Caused by Mg Malnutrition. Foods 10:11, pages 2513.
Crossref
Maitha Abdul-Aziz Al-Tamimi, Syed Wasif Gillani, Mohamed Elhassan Abd Alhakam & Kishore Gnana Sam. (2021) Factors Associated With Hospital Readmission of Heart Failure Patients. Frontiers in Pharmacology 12.
Crossref
Wenlong Ning, Shuhua Li, Dongmei Wei, Long Zhe Guo & Hong Chen. (2021) Automatic Detection of Congestive Heart Failure Based on a Hybrid Deep Learning Algorithm in the Internet of Medical Things. IEEE Internet of Things Journal 8:16, pages 12550-12558.
Crossref
Yunhong Wang, Xuemei Zhao, Mei Zhai, Chaomei Fan, Yan Huang, Qiong Zhou, Pengchao Tian, Tao An, Yuhui Zhang & Jian Zhang. (2021) Elevated urinary albumin concentration predicts worse clinical outcomes in hospitalized acute decompensated heart failure patients. ESC Heart Failure 8:4, pages 3037-3048.
Crossref
Liu He, Zhao‐Jie Dong, Xin Du, Chao Jiang, Ning Chen, Shi‐Jun Xia, Xiao‐Xia Hou, Hai‐Rong Yu, Qiang Lv, Rong‐Hui Yu, De‐Yong Long, Rong Bai, Nian Liu, Cai‐Hua Sang, Chen‐Xi Jiang, Song‐Nan Li, Mark D. Huffman, Jian‐Zeng Dong & Chang‐Sheng Ma. (2021) Healthcare quality and mortality among patients hospitalized for heart failure by hospital level in Beijing, China. ESC Heart Failure 8:2, pages 1186-1194.
Crossref
Wenwen Chen, Yanyan Liu, Longlong Tang, Zhenshan Li, Yanlin Liu & Heqin Dang. (2021) Clinical characteristics, prescription patterns, and persistence associated with sacubitril/valsartan adoption. Medicine 100:30, pages e26809.
Crossref
Lin Bai, Ziyue Xu, Cong Huang, Yunchuan Sui, Xiaodong Guan & Luwen Shi. (2020) Psychotropic medication utilisation in adult cancer patients in China: A cross-sectional study based on national health insurance database. The Lancet Regional Health - Western Pacific 5, pages 100060.
Crossref
Younan Yao, Rongcheng Zhang, Tao An, Xinke Zhao & Jian Zhang. (2020) Cost‐effectiveness of adding dapagliflozin to standard treatment for heart failure with reduced ejection fraction patients in China. ESC Heart Failure 7:6, pages 3582-3592.
Crossref
Yue Wu, Shuo Tian, Peipei Rong, Fan Zhang, Ying Chen, Xianxi Guo & Benhong Zhou. (2020) Sacubitril-Valsartan Compared With Enalapril for the Treatment of Heart Failure: A Decision-Analytic Markov Model Simulation in China. Frontiers in Pharmacology 11.
Crossref
Lin Bai, Haishaerjiang Wushouer, Cong Huang, Zhenhuan Luo, Xiaodong Guan & Luwen Shi. (2020) Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017. Frontiers in Pharmacology 11.
Crossref
Hong Luo, Deborah F. Lindell, Corrine Y. Jurgens, Yongsheng Fan & Liping Yu. (2020) Symptom Perception and Influencing Factors in Chinese Patients with Heart Failure: A Preliminary Exploration. International Journal of Environmental Research and Public Health 17:8, pages 2692.
Crossref
Chaicharn Deerochanawong, Siew P. Chan, Bien J. Matawaran, Wayne H.‐H. Sheu, Juliana Chan, Nguyen H. Man, Ketut Suastika, Chin M. Khoo, Kun‐Ho Yoon, Andrea Luk, Ambrish Mithal & Ji Linong. (2019) Use of sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations. Diabetes, Obesity and Metabolism 21:11, pages 2354-2367.
Crossref
Steve Ryder, Kathleen Fox, Pratik Rane, Nigel Armstrong, Ching-Yun Wei, Sohan Deshpande, Lisa Stirk, Yi Qian & Jos Kleijnen. (2019) A Systematic Review of Direct Cardiovascular Event Costs: An International Perspective. PharmacoEconomics 37:7, pages 895-919.
Crossref
Lucia Giles, Caroline Freeman, Polly Field, Elisabeth Sörstadius & Bernt Kartman. (2020) Humanistic burden and economic impact of heart failure – a systematic review of the literature. F1000Research 8, pages 859.
Crossref
Lucia Giles, Caroline Freeman, Polly Field, Elisabeth Sörstadius & Bernt Kartman. (2019) Humanistic burden and economic impact of heart failure – a systematic review of the literature. F1000Research 8, pages 859.
Crossref
Hyeonseok Cho, Sung-Hee Oh, Hankil Lee, Hyun-Jai Cho & Hye-Young Kang. (2018) The incremental economic burden of heart failure: A population-based investigation from South Korea. PLOS ONE 13:12, pages e0208731.
Crossref
Edimar Alcides Bocchi, FÁtima das Dores da Cruz, Sara Michelly BrandÃo, Victor Issa, Silvia Moreira Ayub-Ferreira, Hans-Peter Brunner la Rocca & Sandra Sanders–van Wijk. (2018) Cost-Effectiveness Benefits of a Disease Management Program:The REMADHE Trial Results. Journal of Cardiac Failure 24:10, pages 627-637.
Crossref
Ping Guo, Richard Harding & Irene J. Higginson. (2018) Palliative care needs of heart failure patients in China: putting people first. Current Opinion in Supportive & Palliative Care 12:1, pages 10-15.
Crossref
S. Stewart, C. Mainland & A. David. 2018. Encyclopedia of Cardiovascular Research and Medicine. Encyclopedia of Cardiovascular Research and Medicine 187 196 .
S. Stewart. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.